CD8A and non-small cell lung carcinoma: In some solid tumors, such as breast cancer [23], bladder cancer [24], and non-small cell lung cancer [25], an increase in the number of CD103+ CD8+ TRM cells corresponds to prolonged disease-free survival and overall survival.